Our 2025 Year In Review Is Here
January 21, 2026 Target ALS
Ending AlS starts with you.
This past year marked a turning point for ALS research. Across the globe, scientists collaborated faster, data moved more freely, and people living with ALS played a more central role in shaping discovery than ever before.
In our newly released 2025 Year In Review, Target ALS shares how our Fund, Enable, Conduct model is accelerating progress at every stage, from uncovering disease biology to advancing therapies toward the clinic. You’ll see what happens when barriers are removed, when data is shared openly, and when urgency meets collaboration.
Inside the report:
- Breakthroughs in drug discovery, biomarkers, and ALS biology
- Global expansion of our ALS Global Research Initiative (AGRI)
- The growing impact of the Target ALS Data Engine
- Stories from scientists, fundraisers, and people living with ALS who are driving change
Progress like this doesn’t happen by accident. It happens because of a community that believes ALS can be treated, and there is a world where Everyone with ALS Lives.
Read the full 2025 Year In Review and see how, together, we are changing what an ALS diagnosis means.
